2024 Italy Hospital Infectious Disease Market for 100 Tests: Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Technologies, Instrumentation and Opportunities
This new report from LeadingMarketResearch.com contains 887 pages, 72 tables, and presents a comprehensive analysis of the Italian hospital infectious disease testing market, including:
Introduction
Worldwide Market and Technology Overview
A. Major Infectious Disease Tests
1. AIDS
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
2. ADENOVIRUS
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
d. Adeno-Associated Viruses(AAV)
3. AEROMONAS
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
4. ANTHRAX/BACILLUS ANTHRACIS
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
5. ARBOVIRUSES
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
6. BABESIOSIS
a. Background
7. BACILLARY EPITHELIOID ANGIOMATOSIS (BEA) AND OTHER
Bartonella (Rochalimaea)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
8. BLASTOCYSTIS HOMINIS
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
9. BRUCELLA
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
10. CAMPYLOBACTER
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
11. CANDIDA
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
12. CHAGAS DISEASE
a. Background
13. CHANCROID
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
14. CHLAMYDIA
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
15. CLOSTRIDIUM DIFFICILE
a. Background
b. Diagnostic Tests
c. Drugs and Vaccines
16. CORONAVIRUSES
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
17. COXSACKIEVIRUSES
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
18. CREUTZFELDT-JAKOB’S DISEASE
a. Background
b. Diagnostic Tests
c. Vaccines
Worldwide Market and Technology Overview
A. Major Infectious Disease Tests
1. AIDS
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
2. ADENOVIRUS
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
d. Adeno-Associated Viruses(AAV)
3. AEROMONAS
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
4. ANTHRAX/BACILLUS ANTHRACIS
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
5. ARBOVIRUSES
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
6. BABESIOSIS
a. Background
7. BACILLARY EPITHELIOID ANGIOMATOSIS (BEA) AND OTHER
Bartonella (Rochalimaea)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
8. BLASTOCYSTIS HOMINIS
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
9. BRUCELLA
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
10. CAMPYLOBACTER
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
11. CANDIDA
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
12. CHAGAS DISEASE
a. Background
13. CHANCROID
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
14. CHLAMYDIA
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
15. CLOSTRIDIUM DIFFICILE
a. Background
b. Diagnostic Tests
c. Drugs and Vaccines
16. CORONAVIRUSES
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
17. COXSACKIEVIRUSES
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
18. CREUTZFELDT-JAKOB’S DISEASE
a. Background
b. Diagnostic Tests
c. Vaccines
More Publications
2019-2023 Competing in the Italy Clinical Chemistry and Immunodiagnostics Market: Analyzers and Reagents-Supplier Shares and Sales Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities
US$ 6,100.00
March 2019
561 pages
Italy Respiratory Diseases Diagnostic Testing Market, 2021
US$ 1,950.00
September 2017
281 pages
2017-2021 Italy Nucleic Acid Testing/NAT Market: Growth Opportunities and Business Expansion Strategies for Instrument and Reagent Suppliers
US$ 6,030.00
February 2017
1117 pages